2018-2023 Mitomycin C Market Research: Global Industry Analysis and Forecast

14
789

In this report, LP Information covers the current scenario (base year being 2017) and the growth prospects of the global Mitomycin C market for 2018-2023.

Mitomycin C market, Mitomycin C is an antibiotic that acts as a double stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation. .).

In recent years, the global Mitomycin C market has witnessed a rapid upward trend, with an average growth rate of 4.76%. In 2016, the worldwide turnover of mitomycin C was nearly 119.83 M USD; actual production is around 17,370 K units.

The global average price of Mitomycin C is on the rise from 6.30 USD / unit in 2012 to 6.90 USD / unit in 2016. With the state of the world economy, prices will be on the rise over time. over the next five years.

The classification of Mitomycin C includes 2 mg, 10 mg, 40 mg and others. The proportion of 2 mg in 2016 is around 41.5% and the proportion is trending downward from 2012 to 2016.

Mitomycin C is widely used in cancer treatment, ophthalmic use, and other fields. The largest proportion of mitomycin C is cancer treatment, and the proportion in 2016 is 69%. The trend of cancer treatment is on the decline.

Japan is the largest supplier of Mitomycin C, with a production market share of nearly 26.5% in 2016. India is the second largest supplier of Mitomycin C Media, enjoying a production market share of nearly 25% in 2016.

North America is the first place of consumption, with a consumption market share of almost 36% in 2016. After North America, Europe is the second place of consumption with a consumer market share by 32.6%.

Over the next five years, LPI (LP Information) predicts that Mitomycin C will register a -2.3% CAGR in terms of revenue, reach $ 100 million by 2023, from $ 120 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Mitomycin C market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information takes into account the value and volume generated from the sales of the following segments:

Segmentation by product type:

2 mg

10 mg

40 mg

Other

Segmentation by application:

Cancer treatment

Ophthalmic use

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

South East Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Inquire here and check the discount for the @ report:

https://www.reporthive.com/enquiry.php?id=1565680&req_type=disc

The report also presents the market competition landscape and corresponding detailed analysis of the major vendors / manufacturers in the market. Major Manufacturers Covered in This Report:

Kyowa-kirin

Intas Pharmaceuticals

Suits you

Bristol-Myers Squibb

Aspen

European specialist pharma

Alkem Laboratories

Varifarma

APOGEPHA

In addition, this report examines the key drivers influencing market growth, opportunities, challenges and risks faced by key manufacturers and the market as a whole. It also analyzes the main emerging trends and their impact on present and future development.

Research objectives:

To study and analyze the global Mitomycin C consumption (value and volume) by key regions / countries, product type and application, historical data from 2013 to 2017, and forecast to 2023.

To understand the structure of Mitomycin C market by identifying its various subsegments.

Focuses on global leading manufacturers of Mitomycin C, to define, describe and analyze sales volume, value, market share, market competition landscape, SWOT analysis and development plans in the next years.

To analyze Mitomycin C with respect to individual growth trends, future prospects, and their contribution to the total market.

Share detailed information on the main factors influencing the growth of the market (growth potential, opportunities, drivers, challenges and risks specific to the industry).

· To project the consumption of Mitomycin C submarkets, with respect to key regions (along with their respective key countries).

· Analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

· To strategically profile the main players and analyze in depth their growth strategies.

Read the full research report study @: https://www.reporthive.com/enquiry.php?id=1565680&req_type=purch

Contents:

Chapter One: Scope of the Report

Chapter Two: Executive Summary

Chapter Three: Overall Mitomycin C by Players

Chapter Four: Mitomycin C by Regions

Chapter Five: Americas

Chapter Six: APAC

Chapter Seven: Europe

Chapter Eight: Middle East and Africa

Chapter Nine: Market Drivers, Challenges and Trends

Chapter Ten: Marketing, Distributors and Customer

Read more…

List of tables and figures:

Figure Mitomycin C consumed in cancer treatment

Figure Global Mitomycin C Market: Cancer Treatment (2013-2018) (K units)

Figure Global Mitomycin C Market: Cancer Treatment (2013-2018) (Million $)

Figure Annual growth in cancer treatment worldwide (in millions of dollars)

Figure Mitomycin C consumed for ophthalmic use

Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (K Units)

Figure Global Mitomycin C Market: Ophthalmic Use (2013-2018) (Million $)

Figure Annual growth in global ophthalmic use (in millions of dollars) and more …



Source by Mike Ross

Comments are closed.